Steven Cohen’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
Other funds holding PLX
Steven Cohen's PLX Position: Q3 2026 in Review
Steven Cohen reduced its Protalix BioTherapeutics (PLX) stake by 49% in Q3 2026, selling an estimated $31.2K and leaving 13,027 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #3771.
Steven Cohen first reported a position in PLX in Q2 2026 and has held it in 2 quarters since. The position peaked at $59.6K in Q2 2026. 107 funds tracked by Wall St. Rank hold PLX as of Q3 2026.
- Steven Cohen held 13,027 shares of Protalix BioTherapeutics worth $36K as of Q3 2026.
- Steven Cohen sold 12,539 Protalix BioTherapeutics shares in Q3 2026, an estimated $31.2K.
- Protalix BioTherapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3771 holding.
- Steven Cohen first reported a position in Protalix BioTherapeutics in Q2 2026 and has held it in 2 quarters since.
- Steven Cohen's Protalix BioTherapeutics position peaked at $59.6K in Q2 2026.
- 107 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.